Press Release October 9, 2021Genentech's Anti-Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation in Alzheimer's Disease 0 0 Share
Press Release October 8, 2021Ad hoc announcement pursuant to Art. 53 LR: Genentech's Anti-Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation in Alzheimer's Disease 0 0 Share
Press Release October 8, 2021[Ad hoc announcement pursuant to Art. 53 LR] Roche's anti-amyloid beta antibody gantenerumab granted FDA Breakthrough Therapy Designation in Alzheimer's disease 0 0 Share
Company Ticker News September 25, 2021Roche Builds Case For Evrysdi Benefits In Younger Spinal Muscular Atrophy Patients 0 0 Share
Press Release September 20, 2021New Phase III Data Support the Benefit of Genentech's Tecentriq in Early-stage Lung Cancer 0 0 Share
Press Release September 20, 2021New Phase III data support the benefit of Roche's Tecentriq in early-stage lung cancer 0 0 Share
Press Release September 17, 2021Roche receives positive CHMP opinion for Gavreto® (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer 0 0 Share
